A multidisciplinary treatment approach using docetaxel, nedaplatin, and 5-FU for advanced esophageal cancer

被引：0
|
作者：
Ohnuma, Hiroyuki [1 ]
Hirakawa, Masahiro [1 ]
Kikuchi, Shohei [1 ]
Sato, Yasushi [2 ]
Takada, Koichi [1 ]
Miyanishi, Koji [1 ]
Kato, Junji [1 ]
机构：
[1] Sapporo Med Univ, Sch Med, Dept Med Oncol, Sapporo, Hokkaido, Japan
[2] Tokushima Univ, Grad Sch, Inst Biomed Sci, Dept Gastroenterol & Oncol, Tokushima, Japan
来源：
ANNALS OF ONCOLOGY | 2017年 / 28卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P1-069
引用
收藏
页数：2
相关论文
共 50 条
  • [1] Nedaplatin and 5-FU combined with radiation in the treatment for esophageal cancer.
    Yamanaka H.
    Motohiro T.
    Michiura T.
    Asai A.
    Mori T.
    Hioki K.
    [J]. The Japanese Journal of Thoracic and Cardiovascular Surgery, 1998, 46 (10): : 943 - 948
  • [2] Efficacy and toxicity of nedaplatin and 5-FU with radiation treatment for advanced esophageal carcinomas
    Kato, H
    Fukuchi, M
    Manda, R
    Nakajima, M
    Miyazaki, T
    Sohda, M
    Masuda, N
    Fukai, Y
    Tsukada, K
    Kuwano, H
    [J]. ANTICANCER RESEARCH, 2003, 23 (04) : 3493 - 3498
  • [3] Neoadjuvant chemotherapy with docetaxel, nedaplatin, and 5-FU for resectable esophageal cancer: A single center retrospective study
    Shindo, S.
    Takayama, T.
    Honma, R.
    Sawai, K.
    Tsuji, Y.
    [J]. ANNALS OF ONCOLOGY, 2021, 32 : S147 - S147
  • [4] Phase I trial of 5-FU, docetaxel, and nedaplatin (UDON) combination therapy for recurrent or metastatic esophageal cancer
    Shinya Ueda
    Hisato Kawakami
    Shinichi Nishina
    Tsutomu Sakiyama
    Yoshikane Nonagase
    Takafumi Okabe
    Takao Tamura
    Kazuhiko Nakagawa
    [J]. Cancer Chemotherapy and Pharmacology, 2015, 76 : 279 - 285
  • [5] Phase I trial of 5-FU, docetaxel, and nedaplatin (UDON) combination therapy for recurrent or metastatic esophageal cancer
    Ueda, Shinya
    Kawakami, Hisato
    Nishina, Shinichi
    Sakiyama, Tsutomu
    Nonagase, Yoshikane
    Okabe, Takafumi
    Tamura, Takao
    Nakagawa, Kazuhiko
    [J]. CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2015, 76 (02) : 279 - 285
  • [6] RESULTS OF NEOADJUVANT CHEMORADIOTHERAPY WITH DOCETAXEL AND 5-FU FOLLOWED BY ESOPHAGECTOMY FOR LOCALLY ADVANCED ESOPHAGEAL CANCER
    Hamai, Y.
    Hihara, J.
    Aoki, Y.
    Emi, M.
    Okada, M.
    [J]. ANNALS OF ONCOLOGY, 2010, 21 : 251 - 251
  • [7] Phase II Study of Combined Chemotherapy with Docetaxel, CDDP and 5-FU for Highly Advanced Esophageal Cancer
    Osaka, Yoshiaki
    Shinohara, Motoo
    Hoshino, Sumito
    Ogata, Takashi
    Takagi, Yu
    Tsuchida, Akihiko
    Aoki, Tatsuya
    [J]. ANTICANCER RESEARCH, 2011, 31 (02) : 633 - 638
  • [8] PHASE II STUDY OF DOCETAXEL AND 5-FLUOROURACIL (5-FU) WITH CONCURRENT RADIOTHERAPY IN PATIENTS WITH ADVANCED ESOPHAGEAL CANCER
    Hihara, J.
    Hamai, Y.
    Emi, M.
    Aoki, Y.
    Miyata, Y.
    Okada, M.
    [J]. ANNALS OF ONCOLOGY, 2010, 21 : 238 - 238
  • [9] A New Candidate Supporting Drug, Rikkunshito, for the QOL in Advanced Esophageal Cancer Patients with Chemotherapy Using Docetaxel/5-FU/CDDP
    Seike, Junichi
    Sawada, Toru
    Kawakita, Naoya
    Yamamoto, Yota
    Yuasa, Yasuhiro
    Yamai, Hiromichi
    Takachi, Hirokazu
    Yoshida, Takahiro
    Tangoku, Akira
    [J]. INTERNATIONAL JOURNAL OF SURGICAL ONCOLOGY, 2011, 2011
  • [10] Concomitant chemoradiotherapy using docetaxel, cisplatin, and 5-FU for patients with advanced hypopharyngeal cancer.
    Shiga, K.
    Ogawa, T.
    Kato, K.
    Asada, Y.
    Kobayashi, T.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (15)
12345